Pharmacological properties of tetrahydronorharmane (tryptoline).
D000700:Analgesics; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002243:Carbolines / Q000494:pharmacology* / Q000633:toxicity; D004326:Drinking / Q000187:drug effects; D004347:Drug Interactions; D004435:Eating / Q000187:drug effects; D005260:Female; D006591:Hexobarbital / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D013997:Time Factors
D000700:Analgesics; D002243:Carbolines; D007211:Indoles; C009804:tryptoline; D006591:Hexobarbital; D001058:Apomorphine